Novartis announced plans to add a new facility in Morrisville, North Carolina, focused on active pharmaceutical ingredient (API) manufacturing for solid dosage tablets, capsules and RNA therapeutics. The facility represents a critical step that will strengthen end‑to‑end US production capability from active ingredients through finished medicines.
Click on the "Follow" button below and you'll get the latest news from Trade and Industry Development via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
Trade and Industry Development title: Trade and Industry Development | Defining Corporate Strategies for Growth